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Left ventricular hypertrophy has a grave prognosis. Ventricular 
arrhythmias may account for a large portion of this poor progno-
sis, but the contribution of coronary artery disease has not been 
excluded. The occurrence of ventricular arrhythmias was investi-
gated by 24 h ambulatory electrocardiographic (ECG) monitoring 
in 49 hypertensive patients who had normal findings on coronary 
arteriography. The presence of left ventricular hypertrophy was 
assessed by both ECG and echocardiography. 
The frequency and complexity of ventricular arrhythmias were 
significantly related to the presence of left ventricular hypertrophy 
whether it was defined by wall thickness (interventricular septum 
or posterior wall :::::1.2 cm) or by left ventricular mass indexed to 
The presence of left ventricular hypertrophy defined both by 
electrocardiogram (ECG) (1-3) or echocardiogram (4-8) is 
established as an independent risk factor for cardiovascular 
mortality, including sudden death. A high incidence of 
ventricular arrhythmias in hypertensive patients with left 
ventricular hypertrophy has been documented in several 
(9-14) but not all (15-17) studies and has been advanced as 
an explanation of this phenomenon. However, the possible 
concomitant contribution of coronary artery disease has 
rarely been studied by coronary arteriography. In addition, 
previous studies defined left ventricular hypertrophy as 
present or absent, and not as a continuous or graded 
variable. We therefore investigated the occurrence of ven-
tricular arrhythmias in a group of hypertensive patients in 
whom epicardial coronary artery disease was excluded by 
angiography and the degree of left ventricular hypertrophy 
was measured by echocardiogram. 
The purposes of the study were 1) to determine the 
frequency and complexity of ventricular arrhythmias as 
related to left ventricular hypertrophy in the absence of 
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height (left ventricular mass/height :::::163 g/m in men and 
:::::121 g/m in women). The relation between left ventricular mass 
or wall thickness to ventricular arrhythmia was graded and 
continuous; for every 1 mm increase in the thickness of interven-
tricular septum or posterior wall there was an associated two- to 
threefold increase, respectively, in the occurrence and complexity 
of ventricular arrhythmias. 
In conclusion, left ventricular hypertrophy is associated with 
an increase in the frequency and complexity of ventricular ar-
rhythmias in the absence of coronary artery disease, and the 
relation is graded and continuous. 
(J Am Coll CardioI1991;17:1277-82) 
coronary artery disease; 2) to evaluate the impact of increas-
ing left ventricular wall thickness and mass on the preva-
lence and grade of ventricular arrhythmias; and 3) to assess 
the effect of increasing left ventricular wall thickness and 
mass on ventricular arrhythmias independent of other fac-
tors, such as blood pressure level, in a group of hypertensive 
patients. 
Methods 
Study patients. The study cohort consisted of 49 hyper-
tensive patients who were recruited from the cardiac cathe-
terization laboratory on the coronary arteriographic finding 
of normal arteries (no luminal narrowing) or minimal coro-
nary artery disease «25% reduction in luminal diameter) 
coupled with a normal left ventricular ejection fraction 
(>50%) as determined by the contrast left ventriculogram. 
The clinical indication for cardiac catheterization in all 
patients was suspected coronary artery disease. Patients 
were considered to have established hypertension if diastolic 
blood pressure measured on one or more outpatient exami-
nations exceeded 140/90 mm Hg or if a history of hyperten-
sion was obtained and patients were placed on antihyperten-
sive therapy. We did not alter the types of medications the 
patients had been receiving. No patient was taking any 
antiarrhythmic drug (except a beta-adrenergic blocker), sed-
ative or antipsychotic drug. Patients gave informed consent 
and the institution's review committee reviewed and ap-
proved the protocol on January 7, 1986. 
0735-1097/91/$3.50 
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Echocardiographic studies. All subjects were studied 
with use of two-dimensional derived M-mode echocardio-
grams in standard views. Three patients were excluded from 
the group of 52 patients screened because an adequate 
echocardiogram could not be obtained. Measurements were 
made according to the recommendations of the American 
Society of Echocardiography using leading edge to leading 
edge conventions (18). Left ventricular internal dimension 
and ventricular septal and left ventricular posterior wall 
thickness were measured at end-diastole as defined by the 
onset of the QRS complex. Left ventricular (LV) mass was 
calculated with the formula of Troy et al. (19): LV mass (g) 
= 1.05 [(LV internal diameter + LV septal thickness + LV 
posterior wall thickness)3 - (LV internal diameter)3]. 
Left ventricular hypertrophy was defined by wall thick-
ness if the interventricular septum or the posterior wall was 
2: 1.2 cm. The criteria developed by the Framingham Heart 
Study (20) were used to define the presence of left ventric-
ular hypertrophy, and were based on the mean value + 2 SD 
for left ventricular mass, left ventricular mass corrected for 
body surface area and left ventricular mass corrected for 
height. The corresponding values were, respectively, 294 g, 
150 mg/m2 and 163 g/m in men and 198 g, 120 g/m2 and 
121 g/m in women. 
Body surface area (in square meters) was calculated from 
the formula (21) 0.0001 x 7l.84 (weight in kg)0.425 x (height 
in cm)O.725. Analyses were carried out with use of these three 
indexes (mass in grams, mass by height and mass by body 
surface area), with essentially the same results. Because 
obesity is a determinant of left ventricular mass, we chose to 
report left ventricular mass indexed to height as the primary 
measure of mass. Relative wall thickness was defined as (2 x 
posterior wall thickness)/Left ventricular end-diastolic di-
mension. 
Ambulatory ECG monitoring. All ambulatory ECG trac-
ings were recorded during one 24 h period of monitoring with 
use of portable tape recorders to obtain two leads corre-
sponding to modified leads V 1 and V 5 within 2 weeks of the 
cardiac catheterization. Each tape was initially scanned with 
the Del Mar Avionic 660 system at a high speed and 
subsequently reviewed for detailed analysis by two cardiol-
ogists who did not know the results of other investigations. 
Ventricular arrhythmias were categorized according to 
the following two classifications: The number of premature 
ventricular complexes per hour over 24 h (absent, 1 to 4, 5 to 
30, > 30/h) and the original Lown-Wolf classification (22) 
(grade I, < 10 premature ventricular complexes/h; grade 2, 
> lO/h; grade 3, multiform; grade 4, couplets and grade 5, 
salvos). Salvos were defined as one or more episodes of at 
least three consecutive ventricular premature complexes at a 
rate 2: 110 beats/min. Electrocardiographic criteria for left 
ventricular hypertrophy were determined by the Romhilt-
Estes and Estes point scoring system (23). 
Serum potassium. The serum potassium level was deter-
mined on the day of hospital admission for cardiac cathe-
terization. Only one patient had hypokalemia (K+ = 
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3.3 mEq/liter); this patient's potassium level was restored to 
normal before the procedure. 
Exclusion criteria. Patients were not included if a techni-
cally satisfactory echocardiogram could not be obtained. 
Also, to study a selected group of hypertensive patients and 
eliminate potential arrhythmogenic concomitant conditions, 
patients were excluded if the echocardiogram showed asym-
metric septal hypertrophy (septal to posterior free wall 
thickness ratio 2: 1.3), left ventricular dilation (diastolic left 
ventricular diameter >5.8 cm), impaired systolic function or 
the presence of valve disease. 
Statistical analysis. All parametric data are expressed as 
mean values ± SD, and differences between patients with 
and without left ventricular hypertrophy were compared 
with a two-tailed t test. Categorical variables were compared 
by a chi-square or Fisher's exact test where appropriate. 
Spearman's rank correlations were used to determine the 
degree of relation between two dependent variables. Deter-
mination of tertiles of wall thickness and left ventricular 
mass were gender-specific. Multiple logistic regression anal-
yses were used to examine whether wall thickness and mass 
constituted independent factors for ventricular arrhythmias. 
The dependent variable in these models was the Lown-Wolf 
classification (yes = II to V, no = 0 to I). Covariates were 
chosen from univariable logistic regression models, and the 
potential covariates examined included age, gender, systolic 
blood pressure, diastolic blood pressure, smoking, diabetes, 
medications (diuretics, beta-blockers, angiotensin-convert-
ing enzyme inhibitor) and serum potassium level. Variables 
with an associated p value ::sO. 1 0 for the logistic coefficient in 
univariate analysis were selected for inclusion in the multiple 
logistic regression model. 
Results 
Clinical features. The clinical characteristics of the pa-
tients with and without left ventricular hypertrophy are 
summarized in Table 1 and the echocardiographic findings in 
Table 2. When left ventricular hypertrophy was defined by 
wall thickness the mean diastolic blood pressure was signif-
icantly higher in the group with left ventricular hypertrophy. 
Women predominated in the group with a higher ventricular 
mass/height ratio, as did patients using angiotensin-
converting enzyme inhibitors. As expected, patients with 
left ventricular hypertrophy had a significantly thicker sep-
tum and posterior wall, a larger left atrial dimension and a 
higher relative wall thickness ratio than those of patients 
without left ventricular hypertrophy. However, when left 
ventricular hypertrophy was defined by ECG, there were no 
significant differences in any echocardiographic measure-
ment between those with and without ECG left ventricular 
hypertrophy. 
Correlation of arrhythmias with hypertrophy. The fre-
quency of ventricular arrhythmias was clearly associated 
with left ventricular hypertrophy as defined echocardio-
graphically (Table 3). Analysis of the complexity of ventric-
lACC Vol. 17. No.6 
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Table 1. Clinical Characteristics of 49 Patients Categorized by Presence or Absence of Echocardiographic and Electrocardiographic Left 
Ventricular Hypertrophy 
IVS or PW LV Mass/Height Ratio ECG 
No LVH LVH NoLVH LVH No LVH LVH 
(n = 15) (n = 34) (n = 14) (n = 35) (n = 42) (n = 7) 
Age (yr) 57.2 ± 7.5 55.4 ± 7.3 55.7 ± 8.7 56 ± 6.9 56.2 ± 7.7 54.1 ± 5.2 
% Male 33.3 23.5 57.1 14.3t 28.6 14.3 
Weight (kg) 80.9 ± 14.7 89.0 ± 19.3 87.3 ± 15.2 86.2 ± 19.6 85.5 ± 18.2 92.5 ± 18.7 
BMI (kg/m2) 30.0 ± 5.6 32.0 ± 6.0 30.3 ± 4.8 31.8 ± 6.3 30.8 ± 5.7 34.8 ± 6.7 
SBP (mm Hg) 143 ± 22 149 ± 21 145 ± 25 148 ± 20 148 ± 23 146 ± 12 
DBP (mm Hg) 74 ± 14 82 ± 11* 79 ± 15 80 ± II 79 ± 13 80 ± 9 
% Smokers 20.0 26.5 21.4 25.7 23.8 28.6 
% Diabetes 13.3 20.6 7.1 22.9 19.0 14.3 
On medication 
% Beta-blocker 26.7 38.2 21.4 40.0 28.6 71.4 
% Diuretic 40.0 41.2 28.6 45.7 40.5 42.9 
% ACE inhibitor 13.3 35.3 0 40.0* 31.0 14.3 
Serum K+ (mEq/liter) 4.3 ± 0.4 4.2 ± 0.4 4.4 ± 0.5 4.2 ± 0.4 4.3 ± 0.4 4.1 ± 0.3 
*p < 0.05; tp < 0.01. ACE = angiotensin-converting enzyme; BMI = body mass index; DBP = diastolic blood pressure; ECG = electrocardiogram; IVS = 
interventricular septum; LV = left ventricular; L VH = left ventricular hypertrophy; PW = posterior wall; SBP = systolic blood pressure. 
ular arrhythmias as assessed by Lown-Wolf classification 
yielded similar results. 
The relation of ventricular arrhythmias to left ventricular 
hypertrophy persisted whether the criterion was wall 
thickness, calculated left ventricular mass or left ventricular 
mass as related to height or body surface area (data not 
shown). 
The values for interventricular septal and posterior wall 
thickness and left ventricular mass/height ratio were sepa-
rated into tertiles and related to ventricular arrhythmias 
(Table 4). The impact of a progressive increase in wall 
thickness on either frequency (Fig. 1) or grade (Fig. 2) of 
ventricular arrhythmias was again apparent. These findings 
indicate that regardless of the cut point chosen to define left 
ventricular hypertrophy, a graded increase in left ventricular 
wall thickness or mass was associated with more premature 
ventricular complexes and more complex ventricular ectopic 
activity. Spearman correlation coefficients between sum of 
wall thickness, left ventricular mass by height and number of 
Table 2. Echocardiographic Findings in 49 Patients 
IVS or PW 
premature ventricular complexes per hour were 0.50 (p < 
0.01) and 0.51 (p < 0.01), respectively. 
The independent association of ventricular wall thickness 
and mass with ventricular arrhythmias was further assessed 
with a logistic regression model. In univariate analyses both 
systolic and diastolic blood pressure were related to ventric-
ular arrhythmias; age, gender, smoking, diabetes, serum 
potassium and use of diuretics, beta-blockers or angiotensin-
converting enzyme inhibitors were not (p > 0.10). Systolic 
blood pressure was used as the covariate in the multivariate 
logistic analyses. 
Odds ratios and their confidence intervals for the associ-
ation of arrhythmias at each level of wall thickness and mass 
are shown in Table 5. There was an overall graded trend 
toward increased ventricular arrhythmias throughout the 
whole range of wall thickness and mass values, independent 
of blood pressure level. For example, when assessing the 
sum of interventricular septal and posterior wall thickness, 
moving to a higher tertile would increase the odds ratio for 
LV Mass/Height Ratio ECG 
No LVH LVH No LVH LVH NoLVH LVH 
(n = 15) (n = 34) (n = 14) (n = 35) (n = 42) (n = 7) 
LAD (em) 3.32 ± 0.34 3.98 ± O.4ot 3.40 ± 0.43 3.93 ± 0.43t 3.81 ± 0.48 3.61 ± 0.54 
IVS(cm) 1.02 ± 0.06 1.35 ± 0.19t 1.06 ± 0.10 1.33 ± o.m 1.24 ± 0.23 1.30 ± 0.22 
PW(cm) 1.01 ± 0.05 1.36 ± 0.15t 1.08 ± 0.13 1.33 ± 0.19t 1.25 ± 0.21 1.27 ± 0.16 
LVEDD (em) 4.46 ± 0.53 4.43 ± 0.51 4.22 ± 0.44 4.52 ± 0.52 4.40 ± 0.50 4.67 ± 0.54 
LVESD (em) 2.88 ± 0.56 2.66 ± 0.50 2.76 ± 0.50 2.71 ± 0.54 2.70 ± 0.52 2.90 ± 0.54 
RWT(%) 46.0 ± 5.2 62.7 ± 12.8t 51.6 ± 8.4 60.0 ± 14.5* 58.0 ± 14.0 55.3 ± 10.7 
*p < 0.05; tp < 0.01; tp < 0.001. LAD = left atrial dimension; LVEDD = left ventricular end-diastolic dimension; LVESD = left ventricular end-systolic 
dimension; RWT = relative wall thickness; other abbreviations as in Table I. 
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Table 3. Prevalence of Ventricular Arrhythmias By Echocardiographic and Electrocardiographic Left Ventricular Hypertrophy (L VH) 
Thickness LV Mass/Height Ratio ECG 
NoLVH LVH NoLVH LVH NoLVH LVH 
(n = 15) (n = 34) (n = 14) (n = 35) (n = 42) (n = 7) 
PVCs!h 
<I 14 (93%) 17 (50%) 13 (93%) 18 (53%) 29 (69%) 2 (29%) 
1-4 1(7%) 6 (18%) 1 (7%) 
5-30 6 (18%) 
>30 5 (15%) 
p value <0.05 
PVCs = premature ventricular complexes; other abbreviations as in Table I. 
the presence and complexity of ventricular arrhythmias by a 
factor of 12.6. These data also indicate that every I mm 
increase in interventricular septal or posterior wall thickness 
was associated with a rate of increase of 2.2 and 2.9, 
respectively, in the occurrence and complexity of ventricu-
lar arrhythmias. 
Discussion 
Previous studies. This study assessed the frequency and 
complexity of ventricular arrhythmias as determined by 24 h 
ambulatory EeG monitoring in hypertensive patients with 
and without left ventricular hypertrophy who had no or 
minimal epicardial coronary artery disease as assessed by 
coronary arteriography. The finding of increased ventricular 
arrhythmias in the patients with left ventricular hypertrophy 
by EeG or echocardiogram is in agreement with most (9-14) 
but not all (15-17) previous studies. In the Framingham 
study (II), which provided the largest sample studied, a 
strong association was demonstrated among all grades of 
ventricular arrhythmias and left ventricular hypertrophy in 
the general population. 
The association of ventricular arrhythmias and left ven-
tricular hypertrophy has also been found using EeG criteria. 
In an early study by Messerli et al. (10), ventricular arrhyth-
mias were more common-and the complex ventricular 
arrhythmias occurred exclusively-in 16 hypertensive pa-
tients with left ventricular hypertrophy by EeG than in 10 
hypertensive patients without hypertrophy or 14 normoten-
sive subjects. These findings were confirmed in a recent 
6 (17%) 7 (17%) 0(0%) 
6 (17%) 3 (7%) 3 (43%) 
5 (14%) 3 (7%) 2 (29%) 
<0.05 <0.01 
study (I7) by the same group. Similarly, in a well designed 
study by McLenachan et al. (9) of 100 hypertensive subjects, 
including 50 with left ventricular hypertrophy by EeG, a 
strong correlation was found between EeG left ventricular 
hypertrophy and the prevalence and complexity of ventric-
ular arrhythmias. 
This association has not been a uniform finding when left 
ventricular hypertrophy was determined by echocardiog-
raphy. In a recent study by Lavie et al. (17) of 94 hyperten-
sive patients, the prevalence and complexity of ventricular 
arrhythmias were not affected by mild to moderate left 
ventricular hypertrophy detected echocardiographically. 
Manyari et al. (16) reported similar findings in 86 apparently 
healthy elderly persons in whom the frequency or complex-
ity of ventricular arrhythmias did not correlate with left 
ventricular mass index. The divergence of our data and those 
from these two studies may be explained by the significantly 
greater wall thickness and left ventricular mass in our 
patients. 
Mechanism. The mechanism of ventricular arrhythmias 
in left ventricular hypertrophy is not well defined. Although 
increased coronary atherosclerosis might be implicated, our 
study demonstrates that the relation of ventricular arrhyth-
mias to left ventricular hypertrophy is independent of coro-
nary atherosclerosis, as all of our patients had no or minimal 
coronary artery disease on arteriography. However, absence 
of stenosis in epicardial coronary arteries does not guarantee 
lack of ischemia. Several other mechanisms can render the 
hypertrophied myocardium susceptible to ischemia. For 
example, patients with left ventricular hypertrophy have 
Table 4. Prevalence of Ventricular Arrhythmias by Tertile of Left Ventricular Wall Thickness 
and Mass 
Sum of !VS and PW Thickness LV Mass/Height Ratio 
1st 2nd 3rd 1st 2nd 3rd 
PVCs/h 
<1 14 (93%) 13 (62%) 4 (31%) 14 (88%) 12 (80%) 5 (28%) 
1-4 1(7%) 2 (9%) 4 (31%) 3 (20%) 4 (22%) 
5-30 4 (19%) 2 (15%) 2 (12%) 4 (22%) 
>30 2 (9%) 3 (23%) 5 (28%) 
p value <0.05 <0.01 
Abbreviations as in Table 1. 
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Figure 1. Distribution of frequency of ventricular premature com-
plexes (PVC) by ventricular wall thickness. 
reduced coronary vascular reserve. and ECG and histologic 
evidence of ischemia develops in the absence of stenosis in 
the coronary arteries (24-27). Other proposed mechanisms 
include the presence of small vessel disease and failure of the 
blood supply to keep pace with the growth of cardiac muscle 
(28,29). 
In a study relevant to ours, Coste et al. (30) subjected 24 
patients with essential hypertension and normal coronary 
arteriographic findings to programmed electrical stimulation. 
The patients were classified into two groups according to the 
presence or absence of left ventricular hypertrophy as 
determined echocardiographically. Programmed electrical 
stimulation initiated intraventricular reentry in 11 (92%) 
of 12 patients with left ventricular hypertrophy versus 
2 (17%) of 12 patients without hypertrophy. Also, nonsus-
tained ventricular tachycardia could not be induced in any 
of the patients without left ventricular hypertrophy, but it 
was reproducible in three of six patients who met both 
Figure 2. Distribution of severity of ventricular arrhythmia by 
ventricular wall thickness. 
o 1st _ 2nd _ 3rd 
Tertile Tertile Tertile 
Lown-Wolf Classification 
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Table 5. Relation of Left Ventricular Thickness and Left 
Ventricular Mass to Ventricular Arrhythmias* 
Adjusted Odds 95% Confidence 
Ratiot Interval 
Sum of IVS and PW thickness 12.6 3.0-53.5 
(per tertile) 
LV mass/height ratio (glm) 10.8 2.6-44.8 
(per tertile) 
LV mass (g) (per tertile) 7.4 2.1-25.5 
LV mass/BSA (glm2 ) 7.3 2.2-24.3 
(per tertile) 
PW (per 0.1 em) 2.9 1.5-5.9 
IVS (per 0.1 em) 2.2 1.3-3.6 
LV mass/height ratio 1.5 1.1-1.9 
(per 10 glm) 
LV mass (per 20 g) 1.5 1.1-2.0 
LV mass/BSA (per 10 glm2 ) 1.4 1.1-1.8 
'Lown-Wolf classification II to V. tAdjustment for systolic blood pres-
sure; p < om for all odds ratios. BSA = body surface area; other abbrevia-
tions as in Table 1. 
echocardiographic and ECG criteria for left ventricular 
hypertrophy. 
These findings support the view that increased left ven-
tricular mass is associated with electrophysiologic distur-
bances that may be related to an increased amount of fibrous 
tissue or altered collagen content (31). 
The graded nature of the relation. Our data indicate that 
this relation is continuous and graded. For every 0.1 em 
increase in interventricular septal thickness, there was an 
associated doubling of the risk of complex arrhythmia, while 
a similar increase (0.1 em) in left ventricular posterior wall 
resulted in a tripling of the risk. When we separated the 
patients into tertiles according to wall thickness, we noted an 
increase in arrhythmia risk by a factor of 12.6 per tertile 
moving toward a thicker wall. This important finding clearly 
indicates that the relation between increasing wall thickness 
and mass on the one hand and ventricular arrhythmias on the 
other is continuous and is present regardless of the cut point 
used to define the presence or absence of left ventricular 
hypertrophy. This relation has also been shown to be inde-
pendent of other factors, including the level of systolic or 
diastolic blood pressure, serum potassium or use of various 
medications including diuretics or angiotensin-converting 
enzyme inhibitors. 
Effects of beta-blockers. Although one third of our pa-
tients were taking a beta-adrenergic blocking agent, and such 
drugs have antiarrhythmic properties, we believe that this 
variable did not affect the integrity of the study. Beta-
blockers were more widely used in patients with left ventric-
ular hypertrophy than in other patients and would have 
tended to blunt the arrhythmias and attenuate their relation 
to ventricular hypertrophy. 
Conclusions. In our study of hypertensive patients, the 
presence of left ventricular hypertrophy was related to a 
higher frequency and complexity of ventricular arrhythmias 
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in the absence of coronary disease. Moreover, a progressive 
increase in left ventricular wall thickness or mass was 
associated with higher grades of ventricular arrhythmias. 
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